Metformine Evolugen

Metformin, the active ingredient in Metformine Evolugen, is a biguanide presented as a unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults.

GNH USA supplies Metformine Evolugen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Evolugen is a biguanide indicated for disorders of glucose metabolism. - Type 2 diabetes mellitus: improves glycaemic control and reduces fasting plasma glucose. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes. - Polycystic ovary syndrome (off‑label): helps restore ovulatory cycles and improve insulin sensitivity.

Metformine Evolugen may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhoea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration of taste perception. - Decreased vitamin B12 levels: may develop with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes. - Hypoglycaemia: when combined with insulin or secretagogues. - Severe gastrointestinal intolerance: persistent vomiting or diarrhoea leading to dehydration.

Before initiating Metformine Evolugen, several safety considerations are recommended. - Renal function: assess creatinine clearance and avoid use in severe renal impairment. - Hepatic function: evaluate liver enzymes, as hepatic disease increases lactic acidosis risk. - Risk of lactic acidosis: avoid in patients with conditions predisposing to hypoxia (e.g., heart failure, severe infection). - Concomitant medications: review for drugs that may impair renal clearance or increase metformin levels. - Elderly patients: start with lower doses and monitor tolerance closely. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metformine Evolugen can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol (excessive intake): enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Diuretics: may reduce renal clearance of metformin. - NSAIDs: can impair renal function, increasing metformin exposure.